User profiles for Grishma Hirode
Grishma HirodeUniversity of Toronto/Toronto Centre for Liver Disease Verified email at mail.utoronto.ca Cited by 1156 |
Trends in the prevalence of metabolic syndrome in the United States, 2011-2016
G Hirode, RJ Wong - Jama, 2020 - jamanetwork.com
Methods| Using National Health and Nutrition Examination Survey (NHANES) data from
2011 to 2016, a cross-sectional, stratified, multistage probability sample of the US population, …
2011 to 2016, a cross-sectional, stratified, multistage probability sample of the US population, …
Off-therapy response after nucleos (t) ide analogue withdrawal in patients with chronic hepatitis B: an international, multicenter, multiethnic cohort (RETRACT-B study)
Background & Aims Functional cure, defined based on hepatitis B surface antigen (HBsAg)
loss, is rare during nucleos(t)ide analogue (NA) therapy and guidelines on finite NA therapy …
loss, is rare during nucleos(t)ide analogue (NA) therapy and guidelines on finite NA therapy …
Trends in the burden of chronic liver disease among hospitalized US adults
G Hirode, S Saab, RJ Wong - JAMA network open, 2020 - jamanetwork.com
Importance One factor associated with the rapidly increasing clinical and economic burden
of chronic liver disease (CLD) is inpatient health care utilization. Objective To understand …
of chronic liver disease (CLD) is inpatient health care utilization. Objective To understand …
Alcoholic liver disease epidemiology in the United States: a retrospective analysis of 3 US databases
OBJECTIVES: Alcoholic liver disease (ALD) prevalence, particularly the subset with advanced
liver disease, is not well defined. Herein, we aim to provide a comprehensive assessment …
liver disease, is not well defined. Herein, we aim to provide a comprehensive assessment …
Increasing burden of hepatic encephalopathy among hospitalized adults: an analysis of the 2010–2014 national inpatient sample
G Hirode, E Vittinghoff, RJ Wong - Digestive diseases and sciences, 2019 - Springer
Background Hepatic encephalopathy (HE) is associated with substantial morbidity and mortality,
contributing significant burden on healthcare systems. Aim We aim to evaluate trends in …
contributing significant burden on healthcare systems. Aim We aim to evaluate trends in …
[HTML][HTML] Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B
Background and Aims Whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF)
differentially affect relapse and outcomes following treatment discontinuation across different …
differentially affect relapse and outcomes following treatment discontinuation across different …
Incidence of hepatic decompensation after nucleos (t) ide analog withdrawal: Results from a large, international, multiethnic cohort of patients with chronic hepatitis B …
METHODS: This is a multicenter cohort study of virally suppressed, end-of-therapy (EOT)
hepatitis B e antigen (HBeAg)-negative CHB patients who stopped NA therapy (n= 1,557). …
hepatitis B e antigen (HBeAg)-negative CHB patients who stopped NA therapy (n= 1,557). …
Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection
…, WP Brouwer, SM Brakenhoff, G Hirode… - Journal of viral …, 2021 - Wiley Online Library
As pegylated interferon alpha (PEG‐IFN‐α) is increasingly used in combination regimens of
novel drugs, we aimed to characterize ALT flares and their relationship with serum HBsAg …
novel drugs, we aimed to characterize ALT flares and their relationship with serum HBsAg …
Ethnicity and insurance-specific disparities in the model for end-stage liver disease score at time of liver transplant waitlist registration and its impact on mortality
A Robinson, G Hirode, RJ Wong - Journal of Clinical and Experimental …, 2021 - Elsevier
Background and aims Disparities in timely referral to liver transplantation (LT) evaluation
persist. We aim to examine race/ethnicity and insurance-specific differences in the Model for …
persist. We aim to examine race/ethnicity and insurance-specific differences in the Model for …
Increasing clinical and economic burden of nonalcoholic fatty liver disease among hospitalized adults in the United States
G Hirode, E Vittinghoff, RJ Wong - Journal of clinical …, 2019 - journals.lww.com
Background: A major driver of the rapidly increasing US clinical and economic burden of
NAFLD is attributed to inpatient health care resource utilization. Methods: We performed a cross…
NAFLD is attributed to inpatient health care resource utilization. Methods: We performed a cross…